Results 111 to 120 of about 889 (147)

Incidence and risk factors for progression of pachychoroid disease spectrum

Purpose: To report the 1-year progression rate and associated risk factors in an Asian cohort of patients with pachychoroid disease spectrum (PDS) phenotype.Methods: We report the 1-year findings from a prospective observational study recruiting subjects
Fong, Angie Hon Chi, Zhao, Jinzhi, Tan, Anna CS, Sim, Shaun, Teo, Kelvin YC, Wong, Wendy Meihua, Fenner, Beau, Su, Xin Yi, Gemmy Cheung, Chui Ming   +8 more
core   +1 more source

Pachychoroid Neovasculopathy Within The Spectrum of Pachychoroid Disease

Trends in Ophthalmology Open Access Journal, 2018
openaire   +1 more source

Characteristics and Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in a Large Cohort of Patients with Pachychoroid Neovasculopathy. [PDF]

J Vitreoretin Dis
Aizouki C, Mishra AV, Loh GK, Ramachandran N, Greve MDJ, Ehmann D, Grewal PS, Seamone ME.   +7 more
europepmc   +1 more source

Clinical Features and Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration and Pachychoroid Neovasculopathy. [PDF]

J Vitreoretin Dis
Khaohoen A, Chantarasorn Y.
europepmc   +1 more source

Pachychoroid neovasculopathy and age-related macular degeneration.

Pachychoroid neovasculopathy and age-related macular degeneration.
Pachychoroid neovasculopathy is a recently proposed clinical entity of choroidal neovascularization (CNV). As it often masquerades as neovascular age-related macular degeneration (AMD), it is currently controversial whether pachychoroid neovasculopathy should be distinguished from neovascular AMD. This is because its characteristics have yet to be well
openaire   +1 more source

Incidence of recurrence and development of polypoidal lesions following half-dose and two-thirds dose photodynamic therapy for pachychoroid neovasculopathy. [PDF]

Sci Rep
Tanaka K, Onoe H, Takeshima K, Kono M, Wakatsuki Y, Kawamura A, Mori R, Nakashizuka H.   +7 more
europepmc   +1 more source

One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroid neovasculopathy. [PDF]

Eye (Lond), 2021
Hikichi T, Kubo N, Yamauchi M.
europepmc   +1 more source

A comparative study of type 1 neovascularization: Neovascular age-related macular degeneration versus pachychoroid neovasculopathy

Purpose: This study aimed to compare type 1 choroidal neovascularization (CNV) characteristics in eyes with pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (nAMD) using optical coherence tomography angiography (OCTA ...
Sonmezer, P, Kurt, E, Kayikcioglu, O, Ilker, SS, Altinisik, M   +4 more
core  

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci, 2020
Kato Y, Oguchi Y, Omori T, Shintake H, Tomita R, Kasai A, Ogasawara M, Sugano Y, Itagaki K, Ojima A, Machida T, Sekine H, Sekiryu T.   +12 more
europepmc   +1 more source

Characteristics of pachychoroid neovasculopathy

Characteristics of pachychoroid neovasculopathy
openaire   +1 more source